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Abstract The prevalence and clinical manifestation of
several cardiovascular diseases vary considerably with sex
and age. Thus, a better understanding of the molecular basis
of these differences may represent a starting point for an
improved gender-specific medicine. Despite the fact that
sex-specific differences have been observed in the cardio-
vascular system of humans and animal models, systematic
analyses of sexual dimorphisms at the transcriptional level
in the healthy heart are missing. Therefore we performed
gene expression profiling on mouse and human cardiac
samples of both sexes and young as well as aged
individuals and verified our results for a subset of genes
using real-time polymerase chain reaction in independent
left ventricular samples. To tackle the question whether sex
differences are evolutionarily conserved, we also compared
sexually dimorphic genes between both species. We found
J Mol Med (2008) 86:61–74
DOI 10.1007/s00109-007-0240-z
Electronic supplementary material The online version of this article
(doi:10.1007/s00109-007-0240-z) contains supplementary material,
which is available to authorized users.
Funding Grants: The project was funded by the Research and Training
Group 754 “Sex- and Gender-Specific Mechanisms in Myocardial
Hypertrophy” (German Research Council, DFG).
J. Isensee: H. Witt:V. Regitz-Zagrosek:P. Ruiz Noppinger (*)
Center for Cardiovascular Research,
Charité Universitätsmedizin Berlin,
Hessische Straße 3-4,
Berlin, Germany
e-mail: ruiz@molgen.mpg.de
URL: http://www.charite.de/ccr/ruiz.html
J. Isensee: H. Witt:V. Regitz-Zagrosek:P. Ruiz Noppinger
Center for Gender in Medicine,
Charité Universitätsmedizin Berlin,
Hessische Straße 3-4,
Berlin, Germany
R. Pregla:R. Hetzer:V. Regitz-Zagrosek
German Heart Institute Berlin,
Augustenburger Platz 1,
Berlin, Germany
J. Isensee: H. Witt:P. Ruiz Noppinger
Department Vertebrate Genomics,
Max Planck Institute for Molecular Genetics,
Ihnestraße 63-73,
Berlin, Germany
JÖRG ISENSEE
did his undergraduate work in
the laboratory of Patricia Ruiz
Noppinger in 2004 and is cur-
rently a PhD fellow in the PhD
programme 754 “Sex- and gen-
der-specific mechanisms in
myocardial hypertrophy” funded
by the German Research Coun-
cil. His research focuses on
molecular mechanisms of sex
differences in the cardiovascular
system and novel concepts of
sex steroid hormone signaling in
particular.
PATRICIA RUIZ NOPPINGER
received her PhD in molecular
biology at the Basel Institute for
Immunology, Switzerland. She
is currently a professor for
“Molecular Basis of Gender
Differences” at the Center for
Gender in Medicine at the
Charité Universitätsmedizin,
Berlin. Her group focuses on
functional genomics (gene ex-
pression profiling, gene trap
mutagenesis and characteriza-
tion of mouse models) in the
context of cardiovascular
diseases.that genes located on sex chromosomes were the most
abundant ones among the sexually dimorphic genes. Male-
specific expression of Y-linked genes was observed in
mouse hearts as well as in the human myocardium (e.g.
Ddx3y, Eif2s3y and Jarid1d). Higher expression levels of
X-linked genes were detected in female mice for Xist,
Timp1 and Car5b and XIST, EIF2S3X and GPM6B in
women. Furthermore, genes on autosomal chromosomes
encoding cytochromes of the monoxygenase family (e.g.
Cyp2b10), carbonic anhydrases (e.g. Car2 and Car3) and
natriuretic peptides (e.g. Nppb) were identified with sex-
and/or age-specific expression levels. This study underlines
the relevance of sex and age as modifiers of cardiac gene
expression.
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Introduction
The identification of sexual dimorphisms at transcriptome
level may be a key towards a better understanding of the
physiological differences between male and female and
may furthermore represent a molecular basis for an
improved gender-specific medicine. Recent studies using
gene expression profiling made significant progress to-
wards elucidating the molecular differences between sexes
in adipose tissue, brain, kidney, liver, skeletal muscle and
reproductive tissues of rodents [1–3]. However, the knowl-
edge regarding sexual dimorphisms in humans is limited for
most somatic tissues [4], and especially in the cardiovas-
cular system, comprehensive investigations are lacking in
rodents and in humans. In contrast, the number of reports
identifying sex-related differences in cardiovascular pheno-
types and physiology is growing. Nowadays, it is well
recognised that there are significant sex differences in
baseline cardiovascular function already in healthy individ-
uals [5]. Furthermore, significant gender-specific differ-
ences have been described regarding the incidence of
cardiovascular disease in human patients including left
ventricular hypertrophy, coronary artery disease and cardiac
remodelling after myocardial infarction [6, 7].
Men with heart failure die off at a faster rate then
women, regardless of treatment. As the cardio-protective
effect of female sex can be found predominantly in
premenopausal, but not postmenopausal women [5], estro-
gens are in the main focus of researchers to decipher the
molecular basis of sex differences in cardiovascular disease.
The biological effects of steroid hormones are classically
mediated by nuclear receptors acting as ligand-activated
transcription factors that bind to specific response elements
located in the promoters of target genes or tether to
transcription factor complexes that contact DNA at alter-
native sites [8, 9]. In addition, a large body of evidence
indicates that steroid hormones exert rapid non-genomic
effects including the activation of MAP kinase pathways
[10]. Therefore, genomic and non-genomic actions of sex
steroid hormones may converge on the regulation of target
genes by modulating the activity of several transcription
factors [9, 10].
Estrogen receptors (ERα and ERβ) are expressed in
endothelial cells, vascular smooth muscle cells and in the
myocardium of both sexes [6]. Additionally, androgen and
progesterone receptors have been identified in the vascula-
ture and myocardium of several species but have received
less attention in the context of cardiovascular physiology. In
animal models, estrogen modulates the response to pressure
overload [11], ischaemia and reperfusion injury [12],
vascular injury [13] and atherosclerosis [14]. Moreover,
estrogen appears to play a protective role in the hypertro-
phic response of the heart to Ca
2+dysregulation [15].
Although the direct effects of estrogen are well character-
ised for some tissues (e.g. the uterus and the mammary
gland), estrogen receptor target genes in the heart have only
been characterised to some extent using isolated cellular
systems in vitro [6]. Furthermore, the molecular mecha-
nisms of steroid hormone action might be indirect by
modulating the release of non-steroidal hormones as it has
been shown for growth hormone (GH). GH is released from
the anterior pituitary in a cyclical manner with high
amplitudes in males and with smaller amplitudes and
higher pulse frequencies in females. Indeed, GH is a major
determinant of sex differences in pubertal body growth
rates and sex-specific gene expression in the rodent liver
[2, 16, 17] by a mechanism involving the transcription
factor signal transducer and activator of transcription 5b
(Stat5b) [16].
In addition to the effects mediated by sex-steroid
hormones, the expression and regulation of sex chromo-
somal genes clearly contribute to sexual dimorphisms [18].
To restore balanced expression of X-linked genes between
sexes, gene dosage compensation mechanisms have
evolved [19]. In females, large parts of one X-allele are
silenced by X-inactivation reducing gene dosage to the
male level. However, some X-linked genes escape X-
inactivation and are therefore expressed from both X-alleles
in females [20]. Newer findings have revealed that the
global balance of diploid gene expression may be estab-
lished by up-regulation of X-chromosomal genes from the
active allele in both sexes. On average, the genes on the
single X-allele give rise to as many transcripts as genes
on autosomal chromosomes, suggesting a twofold up-
regulation of X-linked genes [19].
On the other hand, higher expression levels of X-linked
genes in females might be compensated by the expression
62 J Mol Med (2008) 86:61–74of functionally equivalent Y-linked genes in males. The
male-specific region of the human Y chromosome contains
X-transposed, X-degenerated and ampliconic segments,
respectively [21]. Beside the ampliconic region that
encodes around 100 genes with testis-restricted expression,
homologues of 29 different X-linked genes are localised in
the X-degenerated and the X-transposed region. Whether
protein isoforms encoded by these Y-linked genes are
involved in the development of sexual dimorphisms in
somatic tissues, however, is still unknown. Notably, only 23
protein-coding genes have been annotated on the murine Y-
chromosome so far, underlying that sexual dimorphisms of
sex-chromosome-linked genes might be species-specific.
Animal studies as well as clinical data suggest that
gender-specific differences in the cardiovascular system are
mainly caused by the action of hormones [5]. As sex
steroids and GHs exert their biological effects via nuclear
hormone receptors or other transcription factors at tran-
scriptional level, we assumed that sexual dimorphisms in
cardiac gene expression may be observed already in the
healthy condition and at a young age. In our study, we
therefore aimed to identify evolutionary conserved sexual
dimorphisms in the heart of healthy young and aged mice
as well as human donors.
Materials and methods
Mouse and human tissue samples
C57BL/6J mice were obtained from Harlan-Winkelmann
and kept under standardised SPF conditions and 12-h-light/
12-h-dark cycle with free access to food and water. Animal
housing, care and applications of experimental procedures
complied with the Guide for the Care and Use of
Laboratory Animals of the Government of Berlin, Ger-
many, and are in accordance to the recommendations of the
Society for Laboratory Animal Science (GV-SOLAS) and
the Federation of European Laboratory Animal Science
Associations (FELASA). For microarray analysis, mice
were killed at 2 (six males and six females) and 8 (six males
and six females) months of age, respectively. For real-time
polymerase chain reaction (QPCR), left ventricles (includ-
ing the ventricular septum) were isolated from females at
different stages of the oestrous (n=8 at the proestrus and
n=8 at the diestrus) and from males (n=8) at 3 months of
age, respectively. To asses the oestrous cycle stage in
females, vaginal smears were examined once a day [22].
Animals with at least two consecutive cycles and at a defined
stage underwent cervical dislocation at 6 P.M. Samples were
withdrawn immediately and washed in ice-cold Hank’s
balanced salt solution, flash-frozen in liquid nitrogen and
stored at −80°C.
Human left ventricular myocardial samples were
obtained from explanted donor hearts of <40-year-old
women (n=3), <40 years old men (n=6), 50–65-year-old
women (n=7) and 50–65-year-old men (n=7) at the
German Heart Institute Berlin (DHZB). Human donors
presented no signs of cardiac disease and normal ECG,
echocardiography and laboratory parameters. Morphologi-
cal or histological abnormalities could not be found. The
investigation conforms to the principles outlined in the
Declaration of Helsinki.
Total RNA of individual mouse and human samples was
isolated in parallel using the standard TRIzol® (Invitrogen)
method according to the manufacturer’s protocol. The
concentration and integrity of total RNA was measured
using a 2100 Bioanalyzer (Agilent). Aliquots of mouse and
human RNA samples of each age group were pooled for
microarray analysis. For QPCR analysis RNA samples
were analysed individually. All RNAs were saved before
pooling.
Gene expression analysis
For reverse transcription (Superscript III, Invitrogen) in the
presence of cyanine-coupled deoxycytidine triphosphate
(dCTP; Cy3 or Cy5; Amersham), 50 μg of total RNA were
used in a 30-μl reaction. Labelled complementary DNAs
(cDNAs) were combined with 380 μl TE (10 mM Tris,
1 mM ethylenediamine tetraacetic acid), 20 μg mouse or
human Cot1 DNA and 20 μg Oligo(dA) and purified with a
Microcon YM-30 column (Millipore). Samples were
vacuum-centrifuged and resuspended in 7.5-μl nuclease-
free water, 2.5-μl deposition control targets (Agilent) and
15-μl DIG hybridisation buffer (Roche). Denatured samples
(98°C, 2 min) were hybridised on cDNA microarrays
(Agilent) in a humidified chamber at 42°C for 15 h. Four
independent experiments were carried out for each age
group using exchanged dye-labelled RNA probes (dye-
swap). After washing, microarray slides were scanned using
a microarray scanner (G2565BA, Agilent) and image
analysis was performed with the Feature Extraction
software 7.1.1 (Agilent).
Data analysis
For cDNA microarrays log transformed ratios were ana-
lysed using the Significance Analysis of Microarrays
(SAM) [23]. For comparison of gene lists of different
experiments genes identified by SAM with a false
discovery rate (FDR) <5% and a fold-change >2 were
considered as significantly deregulated. Mouse and human
microarray data are available online at the GEO database
(GSE4793 and GSE4795). Affymetrix datasets (HgU133
Plus 2.0 array) of human myocardial samples from healthy
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downloaded as MAS5.0 text files from the CardioGenomics
website (Genomics of Cardiovascular Development, Adap-
tation, and Remodelling. NHLBI Program for Genomic
Applications, Harvard Medical School. URL: http://www.
cardiogenomics.org). Further analysis was applied to
probes with significant hybridisation signals (detection p
value<0.05) in at least six out of seven samples in at least
one of the sexes. Signal intensities were log transformed
and analysed using SAM. Genes with FDR <5% and fold-
change >2 were considered as significantly deregulated. For
comparison of gene lists between different experiments
gene IDs were mapped to the corresponding UniGene
clusters by the online tool KARMA (Keck ARray Manager
and Annotator).
To interpret the relevance of sexually dimorphic genes,
their overrepresentation in different GeneOntology (GO)
categories and their chromosomal enrichment was deter-
mined using the web-based DAVID tool (Database for
Annotation Visualization and Integrated Discovery, Nation-
al Institute of Allergy and Infectious Disease) [24, 25].
Fisher’s Exact t test was applied to determine whether the
proportion of genes in each GO category (level 5) or
chromosome differed between the sexually dimorphic
genes and the genes present on the microarray.
Quantitative QPCR
Total RNA was reverse transcribed using the Multi-
Scribe™ RT kit (Applied Biosystems) and random hexam-
ers. Subsequently, QPCR reactions were conducted in
triplicate using SYBR-Green I master mix (Applied Bio-
systems) and 10 ng cDNA as template. No template and no
reverse transcriptase controls were included and products
were analysed by gel electrophoresis. PCR efficiency was
determined for single reactions using DART-PCR Version
1.0 [26], and mean PCR efficiency of gene-specific
reactions was used for data analysis. Normalisation and
error propagation were calculated as described at the
geNORM website [27]. The relative quantity of a specific
transcript was calculated as Q=E^(Min(mean Ct of all
samples)-Ct), whereas E represents the mean PCR efficien-
cy. Three different housekeeping genes (Mouse: Hprt1,
Gapdh, Rpl13A; Human: HPRT1, GAPDH, 18S RNA)
were assayed, and a normalisation factor was calculated
from the geometric mean of their expression levels.
Normalised expression levels of target genes were calcu-
lated by dividing the corresponding relative quantity by the
normalisation factor. Statistical significance was assessed
using a two-tailed t test assuming unequal variance of the
biological replicates. Intron-spanning gene-specific primers
were designed using the Primer3 software [28]a n d
sequences are provided in Supplementary Table 4.
Results
Identification of genes with sexually dimorphic expression
To identify genes with sex-biased expression in the human
and mouse heart, we used a cDNA microarray approach
(Fig. 1). Labelled cDNAs were hybridised on microarrays
containing either 8,692 mouse (7,134 UniGene cluster) or
13,169 human cDNA clones (7,782 UniGene cluster),
respectively. The microarrays contained an overlap of
3,009 orthologue genes as determined by mapping the
corresponding UniGene clusters to the HomoloGene re-
source. To differentiate between the pre- and postmeno-
pausal status of human female donors, we arranged the
human myocardial tissue samples into two age groups, one
containing donors younger than 40 years (four men and
three women) and a second one with donors between 50–
65 years of age (five men and five women). Furthermore,
we compared the gene expression patterns between males
and females of 2 and 8 months old mice (n=6 per group),
respectively.
A total of 90 genes in 2 months old and 33 genes in
8 months old mice were considered deregulated between
sexes (fold-change >2, FDR <5%; expression data are
provided in Supplementary Table 1). Some more deregu-
lated genes (93 in young and 125 in aged donors) were
detected using the Agilent platform in the human myocar-
dium (Figs. 1 and 2b). In total, 13 genes in mice (Fig. 2a)
and 14 in humans (Fig. 2b) were identified to be expressed
in a sex-dependent manner irrespective of age. In addition,
we analysed a public dataset (Cardiogenomics) containing
myocardial expression data of seven male and seven female
healthy donors, respectively. Analysis of this dataset
revealed that 37% of all probes had a significant present
call in at least six out of the seven samples in at least one of
the sexes. A total of 16 genes with sex-biased expression
was detected using this platform (Figs. 1 and 2c).
Notably, five genes (EIF1AY, JARID1D, USP9Y,
DDX3Y and RPS4Y1) encoded on the Y chromosome
were detected with human male-specific expression using
both platforms. In a cross-species comparison we found
eight genes showing sex-biased expression in mice as well
as in humans including X inactivation-specific transcript
(Xist/XIST), carbonic anhydrase 3 (Car3/CA3), keratin
8 (Krt2-8, KRT 8), tissue inhibitor of metalloproteinase 1
(Timp1/TIMP1), natriuretic peptide precursor B, serpin
peptidase inhibitor A3 (Serpina3n/SERPINA3), DEAD
(Asp-Glu-Ala-Asp) box polypeptide 3 (Ddx3y/DDX3Y)
and jumonji (Jarid1d/SMCY; Table 1).
To confirm our results by an independent approach, we
determined the expression levels of several genes in all
samples used for the microarray analysis individually by
QPCR. We found that in many cases their expression
64 J Mol Med (2008) 86:61–74correlates significantly with sex and/or age and could
therefore validate the results obtained by microarray
analysis (Figs. 3 and 4). To asses whether the expression
of these genes is affected by the oestrous cycle, we
analysed left ventricular samples of an independent group
of female mice at different stages of the oestrous in
comparison to male littermates. Notably, we could not
detect statistically significant expression differences during
the oestrous cycle for the six genes analysed (Figs. 3 and 4).
Differential expression of X- and Y-linked genes
Genes located on sex chromosomes were the most abundant
ones among the identified sexually dimorphic genes and
represent reliable controls of our experimental setup. In all
datasets, genes on the Y-chromosome were significantly
overrepresented (p<0.05; Table 2 and Fig. 2). Male-specific
expression was observed for the Y-linked genes Jarid1d,
Ddx3y, and Eif2s3y in mouse hearts (Fig. 2a) and for
JARID1D, DDX3Y, EIF1AY, RPS4Y1, USP9Y, UTY, ZFY,
PRKY, CYorf14, CYorf15A, CYorf15B and CD24L4 in the
human myocardium (Fig. 2b,c). In addition, in 8 months old
mice genes on the X-chromosome were overrepresented
including Xist, Gla, Timp1 and Car5b (Fig. 2b). In aged
human samples, the X-linked genes XIST, TIMP1 and
GPM6B were found to be upregulated in females (Fig. 2c).
Differential expression of genes on autosomal
chromosomes
Beside X- and Y-linked genes we detected genes on
autosomal chromosomes with sex-biased expression. In
mice we found an overrepresentation of genes encoded on
chromosome 6 and in humans on chromosomes 1 and 8,
respectively (Table 2). Interestingly, carbonic anhydrases of
the α-subgroup (Car1-3) localised on human chromosome
8 and on mouse chromosome 3 were identified with sex-
biased expression in both species (Table 1). By QPCR we
confirmed higher expression levels of Car3 in whole heart
samples of 2 months old female mice (threefold) as well as
in ventricular samples of 3 months old ones (Fig. 3a,b).
This sexual dimorphism appeared to be independent of the
oestrous cycle (Fig. 3b). QPCR quantification of the human
orthologue CA3 revealed a similar trend only in the group
of older human donors (Fig. 3c). We then quantified the
expression of Car2 in murine hearts and found that this
Fig. 1 Experimental design to screen for genes with sex-biased
expression in the heart of mice and human donors. Total RNA was
isolated from mouse whole heart samples and from myocardial tissue
of human donors. Cyanine dye labelled cDNAs generated from pooled
RNAs were hybridised on Agilent cDNA microarrays. In addition,
human myocardial expression datasets were downloaded from Car-
dioGenomics and filtered for sex-biased genes. Candidate gene lists
were compared to identify sexual dimorphisms in young as well as
aged individuals and both species and platforms. Expression levels of
several candidate genes were quantified individually by real-time PCR
(QPCR) in the same samples used for microarray analysis and in left
ventricular samples from female mice at different stages of the
oestrous as well as from males (n=8 per group). Numbers of
individuals analysed by QPCR are shown in brackets. FDR, false
discovery rate; y, years; mon, months
J Mol Med (2008) 86:61–74 65Fig. 2 Candidate genes identified by microarray approaches. a False
colour representation of the 13 overlapping genes (see also intersec-
tion in the Venn diagram) identified with sex-biased expression in 2 as
well as in 8 months old mice. Fold-changes were calculated from four
technical replicates using pooled total RNA isolated from male and
female whole mouse hearts of both age groups (n=6 per group).
Numbers of genes identified with sex-biased expression in each group
(90 and 33, respectively) are shown in the Venn diagram. b False
colour representation of the 14 overlapping genes (see also intersec-
tion in the Venn diagram) identified with sex-biased expression in
human left ventricular samples of both age groups. Fold-changes were
calculated from four technical replicates using pooled total RNA
isolated from three to five samples per group. Numbers of genes
identified with sex-biased expression in each age group (93 and 125,
respectively) are shown in the Venn diagram. c False colour represen-
tation of the 16 genes identified in the Cardiogenomics dataset with sex-
biased expression in myocardial tissue of male (mean age=53.6 years)
and female (mean age=49.3 years) human donors (n=7 per group).
Note that for some genes sex-biased expression was detected in both
species (e.g. Ddx3y and Jarid1d) as well as in both platforms (USP9Y
and RPS4Y1). Shades of red represent female-biased expression and
blue, male-biased expression in individual samples (FDR <5%, fold-
change >2)
66 J Mol Med (2008) 86:61–74gene appears to be significantly upregulated with age in
both sexes, although predominantly in females (Fig. 3d).
Increased expression of CA2 in older individuals was also
observed in human samples, whereas the fold-changes
where smaller (Fig. 3f). In addition, a twofold higher
expression of the X-linked Car5b gene was found in female
mice of both ages (Fig. 2a).
Several cytochromes of the monoxygenase family were
detected with higher expression levels in the heart of female
mice. The differential expression of Cyp2b10 found using
cDNA microarrays (2.7-fold, Fig. 2a) was confirmed by
QPCR (threefold, Fig. 3g). Interestingly, Cyp2b10 expres-
sion was significantly higher in the 8 months old mice
compared to the younger ones and quantification of the
human orthologue (CYP2B6) revealed a similar trend
(Fig. 3i). Female-biased expression of Cyp2b10 was also
observed in the left ventricle of 3 months old mice
(Fig. 3h), but the fold-change was smaller than in whole
hearts. Furthermore, we detected Cyp2a4 (threefold) and
Cyp2f2 (3.7-fold) being up-regulated in 2 months old as
well as Cyp2b9 in 8 months old female mice (Supplemen-
tary Table 1). In addition, in myocardial samples obtained
from <40-year-old human donors, we identified CYP4B1
with female-biased and CYP2J2 with male-biased expres-
sion (Supplementary Table 1).
Natriuretic peptides have been discussed earlier in the
context of sex-biased gene expression in the heart [29]. We
found female-biased expression of natriuretic peptide
precursor B (Nppb) in old mice (2.7-fold) as well as in
aged human donors (17.2-fold) (Table 1) and both could be
verified by QPCR (Fig. 4d,f). Interestingly, in 2 as well as
in 3 months old mice, a sexual dimorphism of Nppb
expression could not be detected (Fig. 4d,e). Furthermore,
we detected higher expression levels of Nppa in young
female mice compared to males, although the expression
differences were rather small (1.4-fold; Fig. 4a).
Finally, another gene with sex-biased expression was the
orphan nuclear receptor Nr4a1 (Nur77), which was detected
in female mice of both ages with a twofold higher
expression than in males (Fig. 2a). We verified these results
in young females by QPCR (4.5-fold), and a similar trend
was observed in the older ones (1.5-fold) (Fig. 4g). Nr4a1
was found to be significantly down-regulated in older mice,
suggesting that this sexual dimorphism might be more
pronounced in younger individuals. This difference could,
however, not be detected in left ventricular mouse (Fig. 4h)
nor human (Fig. 4i) samples.
To provide insights about the functional relevance of
sexual dimorphisms identified by microarray experiments
in mice and humans, the data obtained was analysed for
Table 1 Cross-species comparison of genes with sex-biased expression in mice as well as in humans
Mouse Human Homolo-
Gene ID
Gene Chr. Protein
2 months
(Agilent)
8 months
(Agilent)
<40 years
(Agilent)
50–65 years
(Agilent)
Affy-
metrix
21.3 56.5 –– 62.4 55839 Ddx3y/
DDX3Y
Y DEAD box
polypeptide 3
6.0 8.7 3.5 2.0 13.7 55838 Jarid1d/
JARID1d
Y Jumonji (SMCY)
−79.3 −81.9 –– 322.6 – Xist/XIST X X inactivation-
specific
transcript
– −2.7 – −17.2 – 49182 Nppb/NPPB 4/1 Natriuretic peptide
precursor B
−3.0 – −2.0 −2.0 – 31298 Car3/CA3 3/8 Carbonic
anhydrase 3
– −2.7 – −2.0 – 36321 Timp1/
TIMP1
X Tissue inhib. of
metalloproteinase
1
−2.6 –– −2.0 – 55643 Krt2-8/
KRT8
15/12 Keratin 8
– −2.2 −2.0 –– 40658 Serpina3n/
SERPINA3
12/14 Serpin peptidase
inhibitor A3
To identify orthologue genes, probe identifiers were mapped to the HomoloGene resource (FDR <5%, fold-change >2). Fold-changes, gene IDs,
chromosomal localization and gene products are given. Note that Jarid1d showed a male-biased expression in both species and both platforms
irrespectively of age.
J Mol Med (2008) 86:61–74 67enriched GeneOntology categories, i.e. biological process
and molecular function (Table 3 and Supplementary
Table 2). We found that genes involved in inflammatory
processes and in chemotaxis were overrepresented in both
species. Murine genes in these categories were predomi-
nantly female-biased (e.g. Sftpd, Ccr7, Ccl7, Ccl25, Ccl28),
whereas human genes were detected with male-biased
expression (e.g. CCL7, CCL11, CCL22, PLAU, IL8,
IL1RN, FOSL1, PTX3). For serpin peptidase inhibitor A3
(SERPINA3/Serpina3n) involved in inflammatory responses,
female-biased expression was detected in both species (see
Table 1). In addition, genes involved in spermatogenesis were
enriched among human sexually dimorphic genes. In terms of
molecular function, only gene products with receptor-binding
activity represented predominantly by CD antigens and
chemokine ligands were overrepresented in both species.
Discussion
The identification of sexually dimorphic genes in the
healthy individual may provide the necessary basis for a
better understanding of the physiological differences be-
tween sexes. Consistent with previous findings for other
organs [1, 3], we identified only a few autosomal genes
with substantial expression differences between sexes (e.g.
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Fig. 3 Analysis of sex-biased gene expression of carbonic anhydrase
3 (Car3), Car2 and cytochrome P450 2b10 (Cyp2b10) in individual
samples. The expression levels of these genes were quantified using
real-time PCR (QPCR) in whole hearts (a, d, g; n=6 per group) as well
as in isolated left ventricles of mice (b, e, h; n=8; 3 months of age)
and human donors (c, f, i; n=3 for <40-year-old women, n=6 for
<40-year-old men, n=7 for 50–65-year-old women and men). Data
represent mean values of relative expression levels normalised to the
geometric mean of reference gene expression levels (HPRT, GAPDH
and 18S) ±SEM. Asterisks indicate levels of significance determined
by two-tailed t tests assuming unequal variance of the biological
replicates. (Asterisks, p<0.05; double asterisk, p<0.01)
68 J Mol Med (2008) 86:61–74Car3 and Cyp2b10). Moreover, we found numerous X- and
Y-linked genes having sex-specific expression in the heart
(e.g. Xist, Ddx3y, and Jarid1d).
To assess whether sexual dimorphisms are tissue
specific, we compared the sexual dimorphisms identified
in our study in the cardiac samples with those described for
other organs (e.g. adipose tissue, kidney, liver, and skeletal
muscle; Supplementary Table 3). Although a significant
overlap was found, the expression of approximately 40% of
these genes was biased in different directions (i.e. female-
biased in the heart and male-biased in another tissue),
suggesting that the mechanisms regulating sex-specific
expression may indeed be tissue-specific in the heart, as
has been shown before for other organs.
Sex-specific expression of X- and Y-linked genes
Genes on the Y-chromosome were found being overrepre-
sented in our as well as in the CardioGenomics datasets and
may therefore represent the main sexual dimorphism at
transcriptional level in the healthy heart. In our study, all
sexually dimorphic Y-linked genes are encoded on the X-
degenerated region of the Y-chromosome and have there-
fore paralogues on the X-chromosome. For the mouse,
brain expression of Y-linked genes was reported to be
compensated by the expression of X-linked homologues
escaping X-chromosomal inactivation [18, 30]. Indeed, we
observed male-specific expression of Y-linked genes (e.g.
Eif2s3y and EIF1AY; Ddx3y) as well as female-biased
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Fig. 4 Analysis of sex-biased gene expression of natriuretic peptide
precursor A (Nppa), Nppb and nuclear receptor 4a1 (Nr4a1) in
individual samples. The expression levels of these genes were
quantified using real-time PCR (QPCR) in whole hearts (a, d, g; n=
6 per group) as well as in isolated left ventricles of mice (b, e, h; n=8;
3 months of age) and human donors (c, f, i; n=3 for <40-year-old
women, n=6 for <40-year-old men, n=7 for 50–65-year-old women
and men). Data represent mean values of relative expression levels
normalised to the geometric mean of reference gene expression levels
(HPRT, GAPDH and 18S) ±SEM. Asterisks indicate levels of
significance determined by two-tailed t tests assuming unequal variance
of the biological replicates. (Asterisks, p<0.05;double asterisk, p<0.01)
J Mol Med (2008) 86:61–74 69expression of their X-linked counterparts (e.g. EIF2S3X,
Ddx3x). We also found male-specific expression of several
Y-linked genes without female-biased expression of their
X-linked homologues (e.g. Jarid1d and Uty), which is
consistent with previous findings [1, 3] and may indicate
that the expression level of some Y-linked genes in somatic
tissues is minor compared to that of their X-linked
homologues. Furthermore, we found substantially more
sexually dimorphic Y-linked genes in the human than in the
mouse heart, which reflects an important species-difference.
Indeed, as the human Y chromosome is three times bigger
in size and encodes almost five times more protein-coding
genes thanthe mouse one, many human genes wefound with
male-specific expression (e.g. RPS4Y1, PRKY, CYorf14,
CYorf15A and CYorf15B) have no murine orthologue on
the mouse Y chromosome.
Besides compensation at the transcriptional level, trans-
lational control mechanisms have also been implicated in
the expression of Y-linked genes in somatic tissues [31].
For instance, the human DDX3Y gene, which we found
being male-specific, is essential for spermatogenesis and is
widely transcribed, but protein expression is limited to the
male germ cells [31]. In contrast, the protein encoded by
the DDX3X gene was found to be expressed ubiquitously.
Ddx3 proteins have similarity to RNA helicases and are
nucleocytoplasmic shuttling proteins that localise to nuclear
membrane pores and facilitate mRNA export [32]. We may
therefore assume a different function of the protein encoded
by DDX3Y in male germ cells than that of DDX3X in other
cell types or tissues. In addition, Y-linked genes involved in
the regulation of translation (e.g. RPS4Y1) or in protein
degradation (e.g. USP9Y) were also found to be expressed
in a male-specific fashion in our study. Interestingly, the
human USP9Y mRNA is expressed in a wide range of adult
and embryonic tissues, including the testis, whereas the
homologous mouse gene is expressed in the testis only
[33]. Consistent with these findings we detected USP9Y
only in the myocardium of male human donors (Fig. 2c).
To what extent, however, sex-biased expression of Y-linked
genes has functional consequences for the heart has still to
be elucidated.
We found female-specific expression of X-linked genes,
including the non-coding RNA Xist, which is associated
with X-chromosome allele silencing in females during X
inactivation [34–36]. The percentage of mammalian X-
linked genes varies between 3.8 and 4.4% depending on the
species [19]. It has been reported that approximately 15%
of them may escape X inactivation [20]. We therefore
expected to identify several X-linked genes with female-
biased expression in the heart. However and in agreement
with previous studies in other organs [3], we only detected a
limited number of X-linked genes with female-biased
expression (e.g. Gla, Car5b, Timp1 and GPM6B). Notably,
GPM6B and TIMP1 were described previously with
inconsistent X inactivation [20]. Furthermore, recent findings
demonstrate that escape from X inactivation might be also
compensated by doubling the expression of X-linked genes
in somatic tissues of males [19]. Our findings therefore
suggest that stringent dosage compensation between sexes
may lead to similar expression levels of X-chromosomal
genes in the heart of both sexes. As escape from X-
inactivation may be associated with maximally twofold up-
Table 2 Overrepresented chromosomes encoding sexually dimorphic genes in the heart of mice and humans
Chr. Percent p value Genes
Mouse hearts, 2 months (Agilent)
Y 3.7 7.9E−04 Eif2s3y, Jarid1d, Ddx3y
6 12.4 2.5E−02 Cd4, Cidec, Clstn3, Tcrb-V13, Gys2, Snca, Lrmp, Cd8a
Mouse hearts, 8 months (Agilent)
Y 9.7 9.6E−05 Eif2s3y, Jarid1d, Ddx3y
X 12.9 5.8E−02 Gla, Xist, Timp1, Car5b
Human left ventricular myocardium, <40 years (Agilent)
Y 4.4 1.7E−03 EIF1AY, USP9Y, RPS4Y1, SMCY
1 16.3 8.2E−02 NEK7, TNNI1, NPPA, TIE1, CYP2J2, PLA2G2A, CYP4B1, RASSF5, GADD45A, RXRG,
ELF3, IL24, PTGFRN, ATF3, PRELP
Human left ventricular myocardium, 50–65 years (Agilent)
Y 2.5 4.0E−02 EIF1AY, USP9Y, RPS4Y1
8 6.6 9.2E−02 DEFA1, CA3, YWHAZ, TNFRSF11B, MYC, CTSB, LPL, XPO7
Human left ventricular myocardium, 50 years (Affymetrix)
Y 61.1 7.7E−18 DDX3Y, UTY, EIF1AY, PRKY, ZFY, USP9Y, CYorf14, RPS4Y1, CYorf15A, CYorf15B,
SMCY
Chromosomal localization, percentage of analysed genes and gene names are given (FDR <5%, fold-change >2; Fisher’s exact test, p<0.05). Note
that genes on the Y chromosome are enriched in both species and age groups among the genes with sex-biased expression.
70 J Mol Med (2008) 86:61–74regulation of gene expression, numerous biological replicates
will be necessary in the future to quantify reliably the
percentage of X-linked genes affected by X inactivation.
Growth hormone influences sex-biased gene expression
Severalstudieshavedemonstratedthatthesex-specificpattern
of GH release is a major mechanistic determinant of sexually
dimorphic gene expression in the rodent liver [2, 17, 37]. A
recent study showed that administration of GH with a male-
specific pattern to female mice resulted in the repression of
female-predominant genes (e.g. Cyp2b10) and in the
induction of male-specific ones [17]. Accordingly, we
detected female-biased expression of Cyp2b10 (Fig. 3g, h).
Although fold-changes were smaller in the left ventricle than
in the whole heart, this difference might be explained by a
predominant expression of Cyp2b10 in the right ventricle, as
it has been shown for its human orthologue CYP2B6 [38].
Cyp2b10 expression increases significantly in the hearts of
mice during aging and a similar trend was observed in
humans (Fig. 3g, i), suggesting that lower GH levels in older
organisms may be associated with a higher expression of
Cyp2b10 as well as a common age-dependent mechanism
of GH in both species. Indeed, higher expression levels of
Cyp2b family members were detected in the hypopituitary
GH-deficient long-lived Ames, Little and Snell dwarf
mice [39, 40]. As Cyp2b enzymes turn over a broad range
of substrates including steroids, fatty acids and xenobiotics,
sex-biased expression levels of these enzymes are likely to
be involved in different drug metabolism observed between
men and women.
Other genes eventually regulated by sex-specific GH
patterns are carbonic anhydrases. They catalyse the revers-
ible hydration of carbon dioxide and participate in a variety
of biological processes, e.g. respiration, calcification, acid-
base balance and bone resorption [41]. We identified
carbonic anhydrases Car2, Car3 and Car5b with female-
biased expression in the heart of either mice and/or human
Table 3 GeneOntology categories of genes with sex-biased expression
Mouse hearts Human myocardium
2 months (Agilent) 8 months (Agilent) <40 years (Agilent) 50–65 years (Agilent) 50 years (Affymetrix)
Biological Process
Cation transport Acute-phase response Apoptosis Antigen presentation Protein biosynthesis
Regulation of signal
transduction
Chemotaxis Cation homeostasis Base-excision repair Spermatogenesis
Second-messenger signaling Inflammatory response Chemotaxis Cell growth
Reg. of calcium-mediated
signaling
Fatty acid metabolism Gas transport
Reg. of immune response Humoral immune response Oxygen transport
Cellular defense response Inflammatory response Regulation of cell size
Chemotaxis Reg. of programmed cell
death
Immune cell activation Response to unfolded protein
Lymphocyte activation Response to virus
Lymphocyte differentiation Spermatogenesis
Molecular Function
Cation binding Antigen binding Receptor binding Enzyme inhibitor
activity
RNA binding
Receptor binding Carbonate dehydratase
act.
DNA binding Unfolded protein
binding
Nucleic acid binding
MHC protein binding Chitinase activity Protein binding Struct. molecule
activity
Hydro-lyase activity Hydrolase activity Signal transducer activity Actin binding
Cytokine activity Cytoskel. protein
binding
Chemokine activity Heme binding
Tetrapyrrole binding
Oxygen transp. activity
Oxygen binding
Genes were annotated according to their biological process and molecular function and analysed for their significant enrichment (FDR <5%, fold-
change >2; Fisher’s exact test, p<0.05). Gene categories enriched in more than one group are highlighted in bold (e.g. inflammatory response and
spermatogenesis as well as receptor binding). A detailed list of all enriched pathways and associated p values is provided in Supplementary Table 2.
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reported for adipose tissue as well as for skeletal muscle
(Supplementary Table 3). In contrast, Car3 gene expression
as well as protein activity have been shown to be male-
predominant in the liver of rodents [3, 42], suggesting
tissue-specific mechanisms in the sex-specific regulation of
Car3 expression. As we observed for Cyp2b10, the
expression levels of Car2 also seem to be associated with
age (Fig. 3d,f).
Sex steroid hormones may influence gene expression
in the heart
To compare gene expression patterns of healthy male and
female cardiac samples may represent a first step towards
identifying sex steroid hormone-responsive genes in the
heart. Lactotransferrin (Ltf) is a well-known estrogen
receptor target gene containing estrogen responsive ele-
ments in the promoter and its expression has been shown to
be regulated in the uterus during the oestrous cycle [43]. In
our study we not only detected Ltf being upregulated in
females (Fig. 2), but its expression in individual whole
hearts correlates with that of other genes such as steroid
15α-hydroxylase (Cyp2a4, Pearson-coefficient r=0.92) and
Cyp2f2 (Pearson-coefficient r=0.93). Therefore, we as-
sumed that the oestrous cycle might be an important
modifier of gene expression in the heart as it has been
shown for the uterus [44]. However, we could not detect
expression of these genes in isolated left ventricles of
females at defined stages of the oestrous cycle. Therefore
chamber-specific expression cannot be excluded and further
investigations will be necessary.
Chamber-specific and/or species-specific differences in
gene expression might also account for the female-biased
expression of the orphan nuclear receptor Nr4a1 (Nurr77,
NGFI-B), which could only be detected in the whole heart
of mice (Figs. 2 and 4). As Nr4a1 is a functional
transcription factor that binds DNA in the absence of a
ligand [45] and is involved in several key biological
processes including gene expression regulation in the
hypothalamic-pituitary adrenal axis [46], it may still
represent a valuable candidate gene for the regulation of
sex-specific differences in the rodent heart.
Sexual dimorphisms in the context of cardiovascular
disease
The basis of sex-specific gene expression in the adult
healthy heart may be relevant for a better understanding
of the gender-specific aspects of human cardiovascular
disease. Indeed, a study screening for human heart failure
responsive genes revealed that the expression of most
candidate genes was affected by age and/or sex [47]. We
identified orosomucoid 1 in the healthy heart of mice as
well as FK506 binding protein 5, integrin beta 1 and
osteoblast-specific factor 2 in human donors with female-
predominant expression. Notably, Weinberg et al. [48]h a d
described these genes to be up-regulated in males and
down-regulated in females upon pressure overload in a
mouse model for left ventricular hypertrophy. Some of
these genes are involved in immune and inflammatory
responses and intriguingly, we found these GO categories
being enriched in the heart as well (Table 3 and Supple-
mentary Table 2) reflecting the striking differences be-
tween sexes regarding the immune system. Although these
findings may substantiate the relevance of sex-specific
gene expression in the healthy heart, to what extent and
with what consequences sex-biased gene expression in the
healthy condition is kept during disease has still to be
elucidated. Such a comparative analysis was not possible
here, as most human data were generated from male
donors or samples not arranged with a gender focus.
Jarid1d (also known as SMCY, selected mouse cDNA on
the Y) is a member of the ARID family that contains DNA-
binding motifs and was detected with male-specific
expression in both species in our study. As it encodes a
male-specific transplantation antigen defined by an octamer
peptide not encoded by the X-linked homologue (SMCX,
Jarid1c), it is presumably involved in the genetic basis of
the antigenic differences between males and females [49].
Interestingly, the related ARID family member Jarid2 was
found to repress atrial natriuretic factor (ANF) expression
during heart development by inhibiting the transcriptional
activity of Nkx2.5 and GATA4 [50]. Although the
functional role of ARID family members has still to be
analyzed, they may play an important role in basic cardiac
physiology.
Natriuretic peptide precursor B (BNP) is not only
considered a well-known prognostic marker for acute and
chronic coronary disease, but also higher plasma levels of
BNP in women as well as in aged patients have been
demonstrated in clinical studies [29, 51]. In our study we
observed no sex-related differences in BNP expression in
young mice, but a significant sexual dimorphism in 8 months
old ones. Accordingly, higher BNP transcript levels were
detected in the heart of aged women, agreeing with the
concept that the strongest predictors of high BNP levels are
age and female sex.
Altogether, we provide a first insight into the sex-specific
gene expression patterns of the heart of healthy mice and
human donors. In future studies, more time points will have
to be considered to distinguish between individuals at
childhood, puberty, adulthood and senescence as well as
comparable whole-genome covering microarray platforms
for both species. In addition, the use of synchronised females
may allow the identification of more estrogen-responsive
72 J Mol Med (2008) 86:61–74genes to elucidate the complex actions of female sex
hormones onto the cardiovascular system. This represents a
challenging task especially in humans, as a higher biological
variability will require the analysis of a large number of
individuals. We would furthermore like to underline the
importance of combining genome-wide expression profiling
with proteomics approaches. In summary, our study suggests
that sex and age represent important modifiers of gene
expression in the mammalian heart and provides a basis for
the analysis of gender-specific mechanisms involved in
cardiac function.
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